Carmen B. Rodriguez
Carmen B. Rodriguez has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Briana Joy Kennedy Stephenson
Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, USA
12 shared publications - Amia Graye
Georgetown University, Washington, District of Columbia
11 shared publications - Cameron Elizabeth Comrie
Harvard Medical School, Boston, Massachusetts
11 shared publications - Chad B. Sussman
Harvard Medical School, Boston, Massachusetts
11 shared publications - Daniel George Packard
Department of Internal Medicine Mayo Clinic Rochester Minnesota USA
11 shared publications - James W. Webber
Brigham and Women's Hospital
11 shared publications
Latest Publications
- Open Access
- 30 March 2026
- Published by Oxford University Press (OUP) in Journal of the Royal Statistical Society Series A: Statistics in Society
A Bayesian mixture model approach to examining neighbourhood social determinants of health in endometrial cancer care in Massachusetts
Many studies examine social determinants of health (SDoH) in isolation, overlooking their interconnected nature. We used a multifactorial approach to construct a neighbourhood-level measure that explores how SDoH jointly impact care received for endometrial cancer (EC) patients in Massachusetts (MA). Using 2015–2019 American Community Survey data, we applied a Bayesian multivariate Bernoulli mixture model to identify MA neighbourhoods with similar SDoH characteristics. Five neighbourhood SDoH (NSDoH) profiles were derived and characterized: (1) advantaged non-Hispanic White; (2) disadvantaged racially/ethnically diverse, more renter-occupied housing with limited English proficiency; (3) working class, lower educational attainment; (4) racially/ethnically diverse and greater economic security and educational attainment; and (5) racially/ethnically diverse, more renter-occupied housing with limited English proficiency. We assigned these profiles to EC patients in the Massachusetts Cancer Registry and used them as the main exposure in a Bayesian logistic regression, adjusting for sociodemographic and clinical characteristics. NSDoH profiles were not associated with optimal care; however, patients in all other profiles had lower odds compared to Profile 1. Our findings demonstrate how a flexible model-based clustering approach captures the multidimensional nature of NSDoH in an interpretable way and may support targeted public health interventions based on neighbourhood-specific social factors to improve healthcare delivery.
- 30 March 2026
- Published by Oxford University Press (OUP) in Journal of the Royal Statistical Society Series A: Statistics in Society
Open AccessA Bayesian mixture model approach to examining neighbourhood social determinants of health in endometrial cancer care in Massachusetts
Many studies examine social determinants of health (SDoH) in isolation, overlooking their interconnected nature. We used a multifactorial approach to construct a neighbourhood-level measure that explores how SDoH jointly impact care received for endometrial cancer (EC) patients in Massachusetts (MA). Using 2015–2019 American Community Survey data, we applied a Bayesian multivariate Bernoulli mixture model to identify MA neighbourhoods with similar SDoH characteristics. Five neighbourhood SDoH (NSDoH) profiles were derived and characterized: (1) advantaged non-Hispanic White; (2) disadvantaged racially/ethnically diverse, more renter-occupied housing with limited English proficiency; (3) working class, lower educational attainment; (4) racially/ethnically diverse and greater economic security and educational attainment; and (5) racially/ethnically diverse, more renter-occupied housing with limited English proficiency. We assigned these profiles to EC patients in the Massachusetts Cancer Registry and used them as the main exposure in a Bayesian logistic regression, adjusting for sociodemographic and clinical characteristics. NSDoH profiles were not associated with optimal care; however, patients in all other profiles had lower odds compared to Profile 1. Our findings demonstrate how a flexible model-based clustering approach captures the multidimensional nature of NSDoH in an interpretable way and may support targeted public health interventions based on neighbourhood-specific social factors to improve healthcare delivery.
- Open Access
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Table 2 from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test
Supplemental Table 2: Correlation between all tested socioeconomic indices and miRNA values for eight miRNA previously associated with ovarian cancer risk, among Massachusetts residents. We confined this analysis to Massachusetts residents given there were a minority of non-Massachusetts residents in the cohort, and zip code was needed to perform the correlations with various socioeconomic indices.
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 2 from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test
Supplemental Table 2: Correlation between all tested socioeconomic indices and miRNA values for eight miRNA previously associated with ovarian cancer risk, among Massachusetts residents. We confined this analysis to Massachusetts residents given there were a minority of non-Massachusetts residents in the cohort, and zip code was needed to perform the correlations with various socioeconomic indices.
- Open Access
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 1 from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test
Supplemental Figure 1: Differences by individual racial subtypes for each of the eight miRNA related to ovarian cancer risk. Values for individual miRNAs were compared across different racial subtypes using pairwise t-tests. The images in this figure are binary, where a 0 (or blue box) indicates a significant p value (p < 0.05) for the pair-wise race-miRNA relation, and a 1 (or yellow box) indicates an insignificant relationship (p ≥ 0.05) between the two racial subtypes compared.
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 1 from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test
Supplemental Figure 1: Differences by individual racial subtypes for each of the eight miRNA related to ovarian cancer risk. Values for individual miRNAs were compared across different racial subtypes using pairwise t-tests. The images in this figure are binary, where a 0 (or blue box) indicates a significant p value (p < 0.05) for the pair-wise race-miRNA relation, and a 1 (or yellow box) indicates an insignificant relationship (p ≥ 0.05) between the two racial subtypes compared.
- Open Access
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Table 1 from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test
Supplemental Table 1: Differences in 179 individual miRNA studied by white vs non-white race/ethnicity. Here we show p-values for both univariate analysis and multiple linear regression analysis controlling for confounding factors. The association with human cancers in the literature is listed for those miRNA that remained significant on multiple linear regression analysis in a separate column.
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 1 from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test
Supplemental Table 1: Differences in 179 individual miRNA studied by white vs non-white race/ethnicity. Here we show p-values for both univariate analysis and multiple linear regression analysis controlling for confounding factors. The association with human cancers in the literature is listed for those miRNA that remained significant on multiple linear regression analysis in a separate column.
- Open Access
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 1 from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test
Supplemental Figure 1: Differences by individual racial subtypes for each of the eight miRNA related to ovarian cancer risk. Values for individual miRNAs were compared across different racial subtypes using pairwise t-tests. The images in this figure are binary, where a 0 (or blue box) indicates a significant p value (p < 0.05) for the pair-wise race-miRNA relation, and a 1 (or yellow box) indicates an insignificant relationship (p ≥ 0.05) between the two racial subtypes compared.
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 1 from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test
Supplemental Figure 1: Differences by individual racial subtypes for each of the eight miRNA related to ovarian cancer risk. Values for individual miRNAs were compared across different racial subtypes using pairwise t-tests. The images in this figure are binary, where a 0 (or blue box) indicates a significant p value (p < 0.05) for the pair-wise race-miRNA relation, and a 1 (or yellow box) indicates an insignificant relationship (p ≥ 0.05) between the two racial subtypes compared.
- Open Access
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Table 2 from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test
Supplemental Table 2: Correlation between all tested socioeconomic indices and miRNA values for eight miRNA previously associated with ovarian cancer risk, among Massachusetts residents. We confined this analysis to Massachusetts residents given there were a minority of non-Massachusetts residents in the cohort, and zip code was needed to perform the correlations with various socioeconomic indices.
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 2 from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test
Supplemental Table 2: Correlation between all tested socioeconomic indices and miRNA values for eight miRNA previously associated with ovarian cancer risk, among Massachusetts residents. We confined this analysis to Massachusetts residents given there were a minority of non-Massachusetts residents in the cohort, and zip code was needed to perform the correlations with various socioeconomic indices.
- Open Access
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Table 3 from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test
Supplemental Table 3 shows the ratio of non-white mean fluorescence units (MFI) to white MFI for the eight miRNA associated with ovarian cancer risk. MFI for non-white patients were on average higher for these race-associated miRNA compared to white patients (significance denoted with an asterisk).
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 3 from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test
Supplemental Table 3 shows the ratio of non-white mean fluorescence units (MFI) to white MFI for the eight miRNA associated with ovarian cancer risk. MFI for non-white patients were on average higher for these race-associated miRNA compared to white patients (significance denoted with an asterisk).
- Open Access
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Table 1 from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test
Supplemental Table 1: Differences in 179 individual miRNA studied by white vs non-white race/ethnicity. Here we show p-values for both univariate analysis and multiple linear regression analysis controlling for confounding factors. The association with human cancers in the literature is listed for those miRNA that remained significant on multiple linear regression analysis in a separate column.
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 1 from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test
Supplemental Table 1: Differences in 179 individual miRNA studied by white vs non-white race/ethnicity. Here we show p-values for both univariate analysis and multiple linear regression analysis controlling for confounding factors. The association with human cancers in the literature is listed for those miRNA that remained significant on multiple linear regression analysis in a separate column.
- Open Access
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Table 3 from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test
Supplemental Table 3 shows the ratio of non-white mean fluorescence units (MFI) to white MFI for the eight miRNA associated with ovarian cancer risk. MFI for non-white patients were on average higher for these race-associated miRNA compared to white patients (significance denoted with an asterisk).
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 3 from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test
Supplemental Table 3 shows the ratio of non-white mean fluorescence units (MFI) to white MFI for the eight miRNA associated with ovarian cancer risk. MFI for non-white patients were on average higher for these race-associated miRNA compared to white patients (significance denoted with an asterisk).
- Open Access
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Data from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test
Serum miRNAs are promising biomarkers for several clinical conditions, including ovarian cancer. To inform equitable implementation of these tests, we investigated the effects of race, ethnicity, and socioeconomic status on serum miRNA profiles. Serum samples from a large institutional biobank were analyzed using a custom panel of 179 miRNA species highly expressed in human serum, measured using the Abcam Fireplex assay via flow cytometry. Data were log-transformed prior to analysis. Differences in miRNA by race and ethnicity were assessed using logistic regression. Pairwise t tests analyzed racial and ethnic differences among eight miRNAs previously associated with ovarian cancer risk. Pearson correlations determined the relationship between mean miRNA expression and the social deprivation index (SDI) for Massachusetts residents. Of 1,586 patients (76.9% white, non-Hispanic), compared with white, non-Hispanic patients, those from other racial and ethnic groups were younger (41.9 years ± 13.2 vs. 51.3 ± 15.1, P < 0.01) and had fewer comorbidities (3.5 comorbidities ± 2.7 vs. 4.6 ± 2.8, P < 0.01). On logistic regression, miRNAs predicted race and ethnicity at an AUC of 0.69 (95% confidence interval, 0.66–0.72), which remained consistent when stratified by most comorbidities. Among eight miRNAs previously associated with ovarian cancer risk, seven significantly varied by race and ethnicity (all P < 0.01). There were no significant differences in SDI for any of these eight miRNAs. miRNA expression is significantly influenced by race and ethnicity, which remained consistent after controlling for confounders. Understanding baseline differences in biomarker test characteristics prior to clinical implementation is essential to ensure instruments perform comparably across diverse populations.Prevention Relevance:This study aimed to understand factors affecting miRNA expression, to ensure we create equitable screening tests for ovarian cancer that perform well in diverse populations. The goal is to ensure that we are detecting ovarian cancer cases earlier (secondary prevention) in women of all races, ethnic backgrounds, and socioeconomic means.
- 2 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test
Serum miRNAs are promising biomarkers for several clinical conditions, including ovarian cancer. To inform equitable implementation of these tests, we investigated the effects of race, ethnicity, and socioeconomic status on serum miRNA profiles. Serum samples from a large institutional biobank were analyzed using a custom panel of 179 miRNA species highly expressed in human serum, measured using the Abcam Fireplex assay via flow cytometry. Data were log-transformed prior to analysis. Differences in miRNA by race and ethnicity were assessed using logistic regression. Pairwise t tests analyzed racial and ethnic differences among eight miRNAs previously associated with ovarian cancer risk. Pearson correlations determined the relationship between mean miRNA expression and the social deprivation index (SDI) for Massachusetts residents. Of 1,586 patients (76.9% white, non-Hispanic), compared with white, non-Hispanic patients, those from other racial and ethnic groups were younger (41.9 years ± 13.2 vs. 51.3 ± 15.1, P < 0.01) and had fewer comorbidities (3.5 comorbidities ± 2.7 vs. 4.6 ± 2.8, P < 0.01). On logistic regression, miRNAs predicted race and ethnicity at an AUC of 0.69 (95% confidence interval, 0.66–0.72), which remained consistent when stratified by most comorbidities. Among eight miRNAs previously associated with ovarian cancer risk, seven significantly varied by race and ethnicity (all P < 0.01). There were no significant differences in SDI for any of these eight miRNAs. miRNA expression is significantly influenced by race and ethnicity, which remained consistent after controlling for confounders. Understanding baseline differences in biomarker test characteristics prior to clinical implementation is essential to ensure instruments perform comparably across diverse populations.Prevention Relevance:This study aimed to understand factors affecting miRNA expression, to ensure we create equitable screening tests for ovarian cancer that perform well in diverse populations. The goal is to ensure that we are detecting ovarian cancer cases earlier (secondary prevention) in women of all races, ethnic backgrounds, and socioeconomic means.